BE856319A - Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite - Google Patents

Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite

Info

Publication number
BE856319A
BE856319A BE178956A BE178956A BE856319A BE 856319 A BE856319 A BE 856319A BE 178956 A BE178956 A BE 178956A BE 178956 A BE178956 A BE 178956A BE 856319 A BE856319 A BE 856319A
Authority
BE
Belgium
Prior art keywords
montmorillonite
pharmaceutical compositions
compositions containing
containing organic
organic derivatives
Prior art date
Application number
BE178956A
Other languages
English (en)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of BE856319A publication Critical patent/BE856319A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE178956A 1976-07-01 1977-06-30 Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite BE856319A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7620143A FR2356425A1 (fr) 1976-07-01 1976-07-01 Application a titre de medicaments de derives organiques de la montmorillonite

Publications (1)

Publication Number Publication Date
BE856319A true BE856319A (fr) 1977-12-30

Family

ID=9175127

Family Applications (1)

Application Number Title Priority Date Filing Date
BE178956A BE856319A (fr) 1976-07-01 1977-06-30 Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite

Country Status (10)

Country Link
US (1) US4096278A (fr)
JP (1) JPS536410A (fr)
AU (1) AU513829B2 (fr)
BE (1) BE856319A (fr)
CA (1) CA1103154A (fr)
DE (1) DE2729824A1 (fr)
FR (1) FR2356425A1 (fr)
GB (1) GB1564458A (fr)
NL (1) NL7707263A (fr)
ZA (1) ZA773747B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2001401A1 (fr) * 1988-10-25 1990-04-25 Claude Piantadosi Derives d'ether ou d'ester lipidique contenant une amine quaternaire et composes therapeutiques
US5244913A (en) * 1991-11-19 1993-09-14 Baxter International Inc. Compositions and methods for dissolving body calculi
DE69431596T4 (de) * 1993-06-10 2003-10-30 University Of North Carolina At Chapel Hill, Chapel Hill (phospho)lipide zum bekämpfen einer hepatitis b-infektion
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
EP0781138B1 (fr) 1994-08-29 2008-05-21 Wake Forest University Analogues de lipides pour le traitement d'infections virales
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
CN1486289A (zh) * 2001-05-29 2004-03-31 皇家菲利浦电子有限公司 金属-陶瓷的结合
WO2003021959A1 (fr) * 2001-08-31 2003-03-13 Thomson Licensing Sa Compteur de sequences destine a un flux audio continu
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
US20120058157A1 (en) * 2007-05-23 2012-03-08 Amcol International Corporation Methods of Treating Cardiovascular Disorders Associated with Atherosclerosis
PL2167069T3 (pl) 2007-05-23 2012-04-30 Amcol International Corp Krzemiany warstwowe oddziałujące z cholesterolem oraz sposoby zmniejszania hipercholesterolemii u ssaka
EP2257173B1 (fr) * 2008-02-27 2014-07-30 Amcol International Corporation Matériau à base de couches de phyllosilicate à échange d'ions hydrogènes protonés pour utilisation dans le traitement de l'athérosclérose

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016209A (en) * 1975-04-23 1977-04-05 Merck & Co., Inc. 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof

Also Published As

Publication number Publication date
ZA773747B (en) 1978-07-26
GB1564458A (en) 1980-04-10
DE2729824A1 (de) 1978-01-05
US4096278A (en) 1978-06-20
FR2356425A1 (fr) 1978-01-27
AU513829B2 (en) 1981-01-08
JPS536410A (en) 1978-01-20
NL7707263A (nl) 1978-01-03
AU2661577A (en) 1979-01-04
FR2356425B1 (fr) 1978-12-15
CA1103154A (fr) 1981-06-16

Similar Documents

Publication Publication Date Title
BE873973A (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
FR2290912A1 (fr) Formulations pharmaceutiques contenant de la l-dopa ou ses derives
BE852444A (fr) Compositions pharmaceutiques anti-inflammatoires
MX9203380A (es) Derivados de carbazolil-(4)-oxi-propanolamina y composiciones farmaceuticas que los contienen.
BE864726A (fr) Compositions pharmaceutiques contenant de la cholestyramine
IT1121238B (it) Derivati di amminotiazoli ad azione farmaceutica
BE851590A (fr) Compositions pharmaceutiques renfermant des pyrethrinoides
BE870531A (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
NL190662C (nl) alfa-Halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat dat dit bevat.
ZA773747B (en) Pharmaceutical compositions containing organic derivatives of montmorillonite
BE871623A (fr) Nouveaux derives du tetrazole et compositions pharmaceutiques les contenant
BE845308A (fr) Derives d'acides phenoxy-alkylcarboxyliques
BE826935A (fr) Compositions pharmaceutiques antivirales
BE864173A (fr) Nouveaux derives de 20,21-dinoreburnamenine, procede de preparation et compositions pharmaceutiques
FR2321294A1 (fr) Derives d'acides 7b-amino-3-cephem-3-carbonylmethyl-4-carboxyliques utiles comme medicaments
BE870265A (fr) Compositions pharmaceutiques anti-inflammatoires
EP0018417A4 (fr) Nouveaux derives de piperidine et compositions pharmaceutiques les contenant.
NO784325L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
FR2335228A1 (fr) Derives de la 5-fluoro-pyrimidine-4-one et medicament contenant ces substances
FR2316931A1 (fr) Derives d'acides dl- et 8 r-9-fluoro-prostadienoiques
BE866100A (fr) Derives de composes du type inter-phenylene-prostaglandine et compositions pharmaceutiques en contenant
BE872647A (fr) Composition pharmaceutique administrable par voie orale
FR2283670A1 (fr) Derives d'acides 19,20-bis-nor-prostanoique, leur preparation et compositions pharmaceutiques les contenant
BE840608A (fr) Nouvelles compositions pharmaceutiques
BE849872A (fr) Compositions pharmaceutiques anti-inflammatoires

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ROUSSEL-UCLAF

Effective date: 19840630